Literature DB >> 26617897

Polymorphism within the distal RAD51 gene promoter is associated with colorectal cancer in a Polish population.

Bartosz Mucha1, Jacek Kabzinski1, Adam Dziki2, Karolina Przybylowska-Sygut1, Andrzej Sygut3, Ireneusz Majsterek1, Lukasz Dziki2.   

Abstract

BACKGROUND: Colorectal cancer (CRC) is one of the most common cancers in developed countries. Annually, over one million of new cases in the world are recorded. Majority of CRCs occur sporadically with dominant phenotype of chromosomal instability (CIN). Permanent exposure to DNA damaging agents such as ionizing radiation result in DNA double-stranded breaks, which create favorable conditions for chromosomal aberration to arise. Homologous recombination repair (HRR) is the leading process engaged in maintaining of the genome integrity. RAD51 protein was recognized as crucial in HRR. Single nucleotide polymorphisms are the primary source of genetic variation which presence in the RAD51 promoter region can affect on its expression and consequently modulate HR efficiency.
OBJECTIVES: The aim of this study was to analyze the distribution of genotypes and allele frequencies of -4791A/T and -4601A/G RAD51 gene polymorphisms, followed by an assessment of their relationship with the risk of CRC.
MATERIAL AND METHODS: The study included 115 patients with confirmed CRC. Control group was consisted of 118 cancer-free individuals with a negative family history. The genotypes were identified by PCR-RFLP method.
CONCLUSION: This study revealed statistically significant association between appearance of G/A genotype in position -4601 of RAD51 gene and CRC risk.

Entities:  

Keywords:  DNA double strand breaks; Homologous recombination repair; colorectal cancer; single nucleotide polymorphism

Mesh:

Substances:

Year:  2015        PMID: 26617897      PMCID: PMC4637713     

Source DB:  PubMed          Journal:  Int J Clin Exp Pathol        ISSN: 1936-2625


  45 in total

Review 1.  Meiotic chromosomes: integrating structure and function.

Authors:  D Zickler; N Kleckner
Journal:  Annu Rev Genet       Date:  1999       Impact factor: 16.830

2.  Measurement of chromosomal DNA single-strand breaks and replication fork progression rates.

Authors:  Claire Breslin; Paula M Clements; Sherif F El-Khamisy; Eva Petermann; Natasha Iles; Keith W Caldecott
Journal:  Methods Enzymol       Date:  2006       Impact factor: 1.600

Review 3.  Relative susceptibilities of male germ cells to genetic defects induced by cancer chemotherapies.

Authors:  Andrew J Wyrobek; Thomas E Schmid; Francesco Marchetti
Journal:  J Natl Cancer Inst Monogr       Date:  2005

4.  Correlation between selected XRCC2, XRCC3 and RAD51 gene polymorphisms and primary breast cancer in women in Pakistan.

Authors:  Z Qureshi; I Mahjabeen; Rm Baig; Ma Kayani
Journal:  Asian Pac J Cancer Prev       Date:  2014

5.  Hypoxia in human colorectal adenocarcinoma: comparison between extrinsic and potential intrinsic hypoxia markers.

Authors:  Laurence Goethals; Annelies Debucquoy; Christiaan Perneel; Karel Geboes; Nadine Ectors; Harlinde De Schutter; Freddy Penninckx; William H McBride; Adrian C Begg; Karin M Haustermans
Journal:  Int J Radiat Oncol Biol Phys       Date:  2006-05-01       Impact factor: 7.038

6.  Cancer incidence and mortality patterns in Europe: estimates for 40 countries in 2012.

Authors:  J Ferlay; E Steliarova-Foucher; J Lortet-Tieulent; S Rosso; J W W Coebergh; H Comber; D Forman; F Bray
Journal:  Eur J Cancer       Date:  2013-02-26       Impact factor: 9.162

Review 7.  The colorectal adenoma-carcinoma sequence.

Authors:  A Leslie; F A Carey; N R Pratt; R J C Steele
Journal:  Br J Surg       Date:  2002-07       Impact factor: 6.939

Review 8.  GammaH2AX and cancer.

Authors:  William M Bonner; Christophe E Redon; Jennifer S Dickey; Asako J Nakamura; Olga A Sedelnikova; Stéphanie Solier; Yves Pommier
Journal:  Nat Rev Cancer       Date:  2008-11-13       Impact factor: 60.716

9.  ABL-fusion oncoproteins activate multi-pathway of DNA repair: role in drug resistance?

Authors:  I Majsterek; A Slupianek; G Hoser; T Skórski; J Blasiak
Journal:  Biochimie       Date:  2004-01       Impact factor: 4.079

10.  Adenoviral vector driven by a minimal Rad51 promoter is selective for p53-deficient tumor cells.

Authors:  Vincent Fong; Marika Osterbur; Cristina Capella; Yo-El Kim; Christopher Hine; Vera Gorbunova; Andrei Seluanov; Stephen Dewhurst
Journal:  PLoS One       Date:  2011-12-09       Impact factor: 3.240

View more
  1 in total

1.  RAD51 and XRCC3 Polymorphisms Are Associated with Increased Risk of Prostate Cancer.

Authors:  Maria Nowacka-Zawisza; Agata Raszkiewicz; Tomasz Kwasiborski; Ewa Forma; Magdalena Bryś; Waldemar Różański; Wanda M Krajewska
Journal:  J Oncol       Date:  2019-05-02       Impact factor: 4.375

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.